velmanase alfa-tycv 10 MG Injection

RxCUI: 2630729
RxNorm name: velmanase alfa-tycv 10 MG Injection
Display name: velmanase alfa-tycv 10 MG Injection
Full name: velmanase alfa-tycv 10 MG Injection
Term type: SCD
Status: DailyMed mapping
Updated: 2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761278	Lamzede	velmanase alfa-tycv	351(a)	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Lamzede	VELMANASE ALFA-TYCV	Chiesi USA, Inc.	36d50a08-60bd-40eb-807c-778d69bf2d2e	2023-02-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2630729

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
36d50a08-60bd-40eb-807c-778d69bf2d2e	velmanase alfa-tycv 10 MG Injection [PSN] · velmanase alfa-tycv 10 MG Injection [SCD]	2	1	These highlights do not include all the information needed to use LAMZEDE ® safely and effectively. See full prescribing information for LAMZEDE . LAMZEDE ( velmanase alfa - tycv ) for injection , for intravenous use Initial U.S. Approval: 2023	20230221